WO2007093849A3 - P100 bactériophage p100 anti monocytogènes de listéria - Google Patents

P100 bactériophage p100 anti monocytogènes de listéria Download PDF

Info

Publication number
WO2007093849A3
WO2007093849A3 PCT/IB2006/004168 IB2006004168W WO2007093849A3 WO 2007093849 A3 WO2007093849 A3 WO 2007093849A3 IB 2006004168 W IB2006004168 W IB 2006004168W WO 2007093849 A3 WO2007093849 A3 WO 2007093849A3
Authority
WO
WIPO (PCT)
Prior art keywords
bacteriophage
control
listeria monocytogenes
ply100
listeriosis
Prior art date
Application number
PCT/IB2006/004168
Other languages
English (en)
Other versions
WO2007093849A2 (fr
Inventor
Martin J Loessner
Original Assignee
Ebi Food Safety B V
Martin J Loessner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ebi Food Safety B V, Martin J Loessner filed Critical Ebi Food Safety B V
Publication of WO2007093849A2 publication Critical patent/WO2007093849A2/fr
Publication of WO2007093849A3 publication Critical patent/WO2007093849A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/097—Preservation
    • A23C19/10—Addition of preservatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3571—Microorganisms; Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

L'invention porte sur des compositions et procédés de traitement et prévention de la listériose utilisant des bactériophages de recombinaison ou des endolysines en dérivant.
PCT/IB2006/004168 2005-09-16 2006-09-15 P100 bactériophage p100 anti monocytogènes de listéria WO2007093849A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71777905P 2005-09-16 2005-09-16
US78374706P 2006-03-17 2006-03-17
US60/783,747 2006-03-17

Publications (2)

Publication Number Publication Date
WO2007093849A2 WO2007093849A2 (fr) 2007-08-23
WO2007093849A3 true WO2007093849A3 (fr) 2008-04-03

Family

ID=38371871

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/004168 WO2007093849A2 (fr) 2005-09-16 2006-09-15 P100 bactériophage p100 anti monocytogènes de listéria

Country Status (1)

Country Link
WO (1) WO2007093849A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008002972A1 (de) * 2008-07-25 2010-01-28 Profos Ag Neues Endolysin PlyP40
US20120128652A1 (en) * 2008-07-25 2012-05-24 Martin Loessner Endolysin plyp40
EP2714898A1 (fr) * 2011-05-26 2014-04-09 DSM IP Assets B.V. Endolysines pour contrôler la listeria dans le fromage fileté à pâte et produits alimentaires associés
CA2872694C (fr) * 2012-05-07 2022-11-15 Micreos B.V. Bacteriophage pour la lutte biologique contre salmonella et dans la fabrication ou le traitement d'aliments
EP3978514A1 (fr) * 2020-10-01 2022-04-06 Micreos Food Safety B.V. Nouveau phage pour la listeria, y compris la listeria monocytogenes
CN113136371A (zh) * 2021-05-29 2021-07-20 甘肃农业大学 基于单增李斯特菌噬菌体的分离及筛选方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004004495A1 (fr) * 2002-07-08 2004-01-15 Exponential Biotherapies, Inc. Phages virulents destines a la lutte contre la listeria monocytogenes dans des produits alimentaires et des usines de transformation des aliments

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004004495A1 (fr) * 2002-07-08 2004-01-15 Exponential Biotherapies, Inc. Phages virulents destines a la lutte contre la listeria monocytogenes dans des produits alimentaires et des usines de transformation des aliments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CARLTON ET AL: "Bacteriophage P100 for control of Listeria monocytogenes in foods: Genome sequence, bioinformatic analyses, oral toxicity study, and application", REGULATORY TOXICOLOGY AND PHARMACOLOGY, ACADEMIC PRESS,NEW YORK, NY,, US, vol. 43, no. 3, December 2005 (2005-12-01), pages 301 - 312, XP005153177, ISSN: 0273-2300 *

Also Published As

Publication number Publication date
WO2007093849A2 (fr) 2007-08-23

Similar Documents

Publication Publication Date Title
WO2007093849A3 (fr) P100 bactériophage p100 anti monocytogènes de listéria
WO2008057208A3 (fr) Inhibiteurs de protéase ns3 du vhc
WO2008051475A3 (fr) Inhibiteurs de la protéase ns3 du vhc
WO2007081974A3 (fr) Traitement de l'hépatite virale
WO2005087731A8 (fr) Composes soufres en tant qu'inhibiteurs de la protease serine ns3 du virus de l'hepatite c
WO2005087721A3 (fr) Nouveaux composes en tant qu'inhibiteurs de la protease serine ns3 du virus de l'hepatite c
WO2006104945A3 (fr) Therapies contre l'hepatite c
TW200740850A (en) HCV NS3 protease inhibitors
WO2010039534A3 (fr) Inhibiteurs viraux et fongiques
MX2012001916A (es) Uso combinado de trampas gdf y activadores de receptor de eritropoyetina para incrementar los niveles de globulos rojos.
WO2008057995A3 (fr) Inhibiteurs de protéase de vhc
WO2007092645A3 (fr) Nouvelles combinaisons d'inhibiteurs du vhc et méthodes
NO20092053L (no) HCV NS3-proteaseinhibitorer
WO2005051980A8 (fr) Inhibiteurs depourvus de liaisons peptidiques de la protease ns3 du virus de l'hepatite c
WO2007084435A3 (fr) Procedes de traitement de l'hepatite c
WO2008133663A3 (fr) Compositions immunogènes à codons modifiés et procédés d'utilisation
MX2010001650A (es) Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales.
WO2006066079A3 (fr) Composes de pyridazinone
WO2010056640A3 (fr) Compositions et méthodes comportant des variantes de protéase à serine
WO2007075901A3 (fr) Promedicaments de modulateurs de transporteurs abc
MX2011006631A (es) Inhibidores de proteasa ns3 del virus hcv.
WO2009067191A3 (fr) Procédés et compositions pour le traitement d'une infection par le virus de l'hépatite c (vhc)
MX2011009644A (es) Inhibidores del virus de la hepatitis c.
ATE513844T1 (de) Acylsulfonamidverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
WO2004002940A8 (fr) Inhibiteurs de la polymerase du vhc (ns5b)

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06849509

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06849509

Country of ref document: EP

Kind code of ref document: A2